Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson’s disease patients? A Systematic Review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson’s disease patients? A Systematic Review
Authors
Keywords
Parkinson’s Disease, Cognition, CSF biomarkers, Longitudinal
Journal
NEUROPSYCHOLOGY REVIEW
Volume 25, Issue 4, Pages 411-423
Publisher
Springer Nature
Online
2015-12-01
DOI
10.1007/s11065-015-9307-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in Alzheimer’s Disease Drug Development
- (2015) Michael S Rafii et al. BMC Medicine
- CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
- (2015) Changqin Liu et al. PARKINSONISM & RELATED DISORDERS
- Biomarkers of cognitive decline in Parkinson's disease
- (2015) Chin-Hsien Lin et al. PARKINSONISM & RELATED DISORDERS
- THE ALZHEIMER'S PREVENTION INITIATIVE
- (2014) Pierre N. Tariot et al. Alzheimers & Dementia
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
- (2014) Tessandra Stewart et al. AMERICAN JOURNAL OF PATHOLOGY
- Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
- (2014) Cristina Nombela et al. BRAIN
- Detection of Cognitive Impairment and Dementia Using the Animal Fluency Test: The DECIDE Study
- (2014) Rolf Sebaldt et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
- (2014) Hana Přikrylová Vranová et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- What can biomarkers tell us about cognition in Parkinson's disease?
- (2014) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Cognitive deficits in Parkinson's disease: A cognitive neuroscience perspective
- (2014) Trevor W. Robbins et al. MOVEMENT DISORDERS
- The neurobiological basis of cognitive impairment in Parkinson's disease
- (2014) Glenda M. Halliday et al. MOVEMENT DISORDERS
- CSF A 42 predicts early-onset dementia in Parkinson disease
- (2014) G. Alves et al. NEUROLOGY
- CSF biomarkers and clinical progression of Parkinson disease
- (2014) S. Hall et al. NEUROLOGY
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
- (2013) Jing Zhang et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration
- (2013) Carole S. Scherling et al. ANNALS OF NEUROLOGY
- Cognitive Change in Newly-Diagnosed Patients with Parkinson's Disease: A 5-Year Follow-up Study
- (2013) Mark Broeders et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
- (2013) David J. Irwin et al. NATURE REVIEWS NEUROSCIENCE
- Evolution of mild cognitive impairment in Parkinson disease
- (2013) M. Broeders et al. NEUROLOGY
- Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study
- (2013) A. J. Yarnall et al. NEUROLOGY
- Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease
- (2013) Kaj Blennow et al. NEUROPSYCHOPHARMACOLOGY
- Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
- (2013) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- The A4 trial: Anti-amyloid treatment of asymptomatic Alzheimer's disease
- (2012) Reisa Sperling et al. Alzheimers & Dementia
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- Cognitive Impairment in Parkinsons Disease: The Dual Syndrome Hypothesis
- (2012) Angie A. Kehagia et al. Neurodegenerative Diseases
- Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study)
- (2011) W. G. J. Reid et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- (2010) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease
- (2010) Angie A Kehagia et al. LANCET NEUROLOGY
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance
- (2010) Michael Ewers et al. NEUROBIOLOGY OF AGING
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease
- (2010) James B. Leverenz et al. PARKINSONISM & RELATED DISORDERS
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
- (2009) Caroline H. Williams-Gray et al. BRAIN
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
- (2009) Yaroslau Compta et al. MOVEMENT DISORDERS
- Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
- (2008) Lucilla Parnetti et al. BIOLOGICAL PSYCHIATRY
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease
- (2008) Gisela Llebaria et al. MOVEMENT DISORDERS
- The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease
- (2008) David J. Gill et al. MOVEMENT DISORDERS
- Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
- (2008) D. Aarsland et al. NEUROLOGY
- Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature
- (2008) Breno S. O. Diniz et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Serum heart-fatty acid binding protein levels in patients with Lewy body disease
- (2007) Kenji Wada-Isoe et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now